Form D · Biotechnology
Cellsound Aesthetics LTD
Jerusalem, L3 · CIK 0001955896
Offering snapshot reported Dec 7, 2022 · SEC filing
- Reported sold
- $2.05M Offering amount: $2.2M
- Investors reported
- 26 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Jul 19, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 7, 2022 | Initial | $2,050,000 | No comparison | 26 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-466843
Source: Form D, filed Dec 7, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mordechai Motti Oderberg | Director, Executive |
| Mark Rodriguez | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1 Agudat Sport Hapoel
Jerusalem, L3, 9695801
Jerusalem, L3, 9695801